FDA Import Program Would Need Funds To Inspect All U.S. Pharmacies, Agency Maintains
This article was originally published in The Pink Sheet Daily
Executive Summary
The pharmacy industry has told FDA all U.S. pharmacies will need to participate in a drug importation program to stay in business, so up to 55,000 pharmacies would have to be inspected, FDA's McGinnis says. "Draconian" penalties for non-complying drug manufacturers would ensure ample flow of drugs from Canada, he says.
You may also be interested in...
AARP Will Continue To Support Dorgan/Snowe Drug Import Bill In 2005
The organization maintains that the Dorgan bill addresses the safety concerns contained in the HHS Importation Task Force report. AARP’s legislative agenda includes supporting proposals to make Medicaid more efficient and expanding its Medicare Rx awareness campaign.
AARP Will Continue To Support Dorgan/Snowe Drug Import Bill In 2005
The organization maintains that the Dorgan bill addresses the safety concerns contained in the HHS Importation Task Force report. AARP’s legislative agenda includes supporting proposals to make Medicaid more efficient and expanding its Medicare Rx awareness campaign.
Rx Import Bills Do Not Have Adequate Funding For FDA, Agency Says
Senate bills "do not go far enough" in allowing FDA to assure safety and efficacy of imported drugs, FDA's Hubbard tells Judiciary Committee hearing. Senate Health Committee will mark up Sen. Gregg's import bill July 21.